See more : Sino-Agri Leading Biosciences Co.,Ltd (603970.SS) Income Statement Analysis – Financial Results
Complete financial analysis of RTW Venture Fund Limited (RTW.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of RTW Venture Fund Limited, a leading company in the Asset Management industry within the Financial Services sector.
- UTI Inc. (179900.KQ) Income Statement Analysis – Financial Results
- C’sMEN Co.,Ltd. (3083.T) Income Statement Analysis – Financial Results
- Taiji Computer Corporation Limited (002368.SZ) Income Statement Analysis – Financial Results
- Hyosung Advanced Materials Corporation (298050.KS) Income Statement Analysis – Financial Results
- Priority Income Fund, Inc. (PRIF-PH) Income Statement Analysis – Financial Results
RTW Venture Fund Limited (RTW.L)
About RTW Venture Fund Limited
RTW Venture Fund Limited specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.17M | -36.51M | -60.92M | 162.77M | 39.71M | 27.99M |
| Cost of Revenue | 82.13M | 3.75M | 0.00 | 2.91M | 368.61K | 0.00 |
| Gross Profit | -77.95M | -40.26M | -60.92M | 159.86M | 39.34M | 27.99M |
| Gross Profit Ratio | -1,869.17% | 110.28% | 100.00% | 98.21% | 99.07% | 100.00% |
| Research & Development | 474.51K | 742.74K | 237.98K | 130.49K | 97.97K | 6.42K |
| General & Administrative | 3.10M | 2.93M | 3.43M | 2.12M | 992.71K | 70.62K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.10M | 2.93M | 3.43M | 2.12M | 992.71K | 70.62K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.69M | 2.93M | 3.43M | 2.12M | 992.71K | 70.62K |
| Cost & Expenses | 86.30M | 2.93M | 3.43M | 2.12M | 992.71K | 70.62K |
| Interest Income | 2.42M | 635.86K | 363.67K | 70.29K | 76.51K | 0.00 |
| Interest Expense | 1.56M | 779.99K | 215.61K | 73.55K | 17.48K | 0.00 |
| Depreciation & Amortization | 0.00 | 4.51M | 7.58M | 4.88M | 1.28M | 70.62K |
| EBITDA | 0.00 | 0.00 | -56.20M | 0.00 | 0.00 | 27.92M |
| EBITDA Ratio | 0.00% | 105.88% | 105.62% | 98.70% | 97.50% | 99.75% |
| Operating Income | -2.51M | -38.66M | -64.34M | 160.65M | 38.72M | 27.92M |
| Operating Income Ratio | -60.30% | 105.88% | 105.62% | 98.70% | 97.50% | 99.75% |
| Total Other Income/Expenses | 85.71M | -779.99K | -57.11M | 165.36M | 40.06M | 0.00 |
| Income Before Tax | 83.19M | -39.44M | -64.34M | 160.65M | 38.72M | 27.92M |
| Income Before Tax Ratio | 1,994.76% | 108.02% | 105.62% | 98.70% | 97.50% | 99.75% |
| Income Tax Expense | 0.00 | -4.51M | -64.34M | 160.65M | 38.72M | -161.14K |
| Net Income | 83.19M | -39.44M | -64.34M | 160.65M | 38.72M | 27.92M |
| Net Income Ratio | 1,994.76% | 108.02% | 105.62% | 98.70% | 97.50% | 99.75% |
| EPS | 0.40 | -0.17 | -0.27 | 0.67 | 0.27 | 0.17 |
| EPS Diluted | 0.40 | -0.17 | -0.27 | 0.67 | 0.27 | 0.17 |
| Weighted Avg Shares Out | 208.88M | 231.98M | 238.31M | 239.78M | 143.40M | 161.54M |
| Weighted Avg Shares Out (Dil) | 208.88M | 231.98M | 238.31M | 239.78M | 143.40M | 161.54M |
Source: https://incomestatements.info
Category: Stock Reports